Fas promoter region gene polymorphism is associated with an increased risk for myocardial infarction

Hypertension Research

Volumn 32, Issue 4, 2009, Pages 261-264

  Hanasaki, Hiroko ^a   Takemura, Yukihiro ^a   Fukuo, Keisuke ^b   Ohishi, Mitsuru ^a   Onishi, Miyuki ^a   Yasuda, Osamu ^a   Katsuya, Tomohiro ^a   Awata, Nobuhisa ^c   Kato, Norihiro ^d   Ogihara, Toshio ^e   Rakugi, Hiromi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MUKOGAWA WOMEN'S UNIVERSITY   (Japan)

^c OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^d NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^e OSAKA GENERAL MEDICAL CENTER   (Japan)

Author keywords

Apoptosis; Fas; Gene polymorphism; Myocardial infarction; VSMCs

Indexed keywords

ADENOSINE; FAS ANTIGEN; GAMMA INTERFERON; GUANOSINE; STAT1 PROTEIN;

ACUTE HEART INFARCTION; ADULT; AGED; APOPTOSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; HUMAN CELL; HYPERTENSION; INCIDENCE; JAPANESE; MAJOR CLINICAL STUDY; MALE; PROMOTER REGION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOOTH MUSCLE FIBER; UPREGULATION; VASCULAR SMOOTH MUSCLE;

AGED; ANTIGENS, CD95; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; JAPAN; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK; STAT1 TRANSCRIPTION FACTOR;

EID: 77952317253     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2009.2     Document Type: Article

References (34)

1. Saraste A, Pulkki K, Kallajoki M, Henriksen K, Parvinen M, Voipio-Pulkki LM, Apoptosis in human acute myocardial infarction, Circulation 1997; 95: 320-323.
2. Isner JM, Kearney M, Bortman S, Passeri J, Apoptosis in human atherosclerosis and restenosis, Circulation 1995; 91: 2703-2711.
3. Walsh K, Smith RC, Kim HS, Vascular cell apoptosls in remodeling, restenosis, and plaque rupture, Circ Res 2000; 87: 184-188. (Pubitemid 30626424)
4. Bjorkerud S, Bjorkerud B, Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability, Am J Pathol 1996; 149: 367-380. (Pubitemid 26256326)
5. Nagata S, Apoptosis regulated by a death factor and its receptor: Fas ligand and Fas. Philos Trans R Soc Lond B Biol Sci 1994; 345: 281-287.
6. Nagata S, Apoptosis by death factor, Cell 1997; 88: 355-365
7. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S, The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis, Cell 1991; 66: 233-243. (Pubitemid 121001362)
8. Straus SE, Jaffe ES, Puck JM, Dale JK, Elkon KB, RÖsen-Wolff A, Peters AM, Sneller MC, Hallahan CW, Wang J, Fischer RE, Jackson CM, Lin AY, Bäumler C, Siegert E, Marx A, Vaishnaw AK, Grodzicky T, Fleisher TA, Lenardo MJ, The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis, Blood 2001; 98: 194-200.
9. Vaishnaw AK, Orlinick JR, Chu JL, Krammer PH, Chao MV, Elkon KB, The molecular basis for apoptotic defects In patients with CD95 (Fas/Apo-1) mutations, J Clin Invest 1999; 103: 355-363
10. Fisher GH, Rosenberg FJ, Straus SE, Dale JK, Middleton LA, Lin AY, Strober W, Lenardo MJ, Puck JM, Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome, Cell 1995; 81: 935-946
11. Rieux-Laucat F, Le Deist F, HivrozC, Roberts IA, Debatin KM, Fischer A, deVillartay JP, Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity, Science 1995; 268: 1347-1349
12. InazawaJ, ltoh N, Abe T, Nagata S, Assignment of the human Fas antigen gene (Fas) to 10q24.l. Genomics 1992; 14: 821-822
13. Huang QR, Morris D, Manolios N, Identification and characterization of polymorphisms in the promoter region of the human Apo-1/Fas (CD95) gene, Mol Immunol 1997; 34: 577-582 (Pubitemid 27512871)
14. Cheng J, Liu C, Koopman WJ, Mountz JD, Characterization of human Fas gene, Exon/ intron organization and promoter region, J Immunol 1995; 154: 1239-1245
15. Kanemitsu S, lhara K, Saifddin A, Otsuka T, Takeuchi T, Nagayama J, Kuwano M, Hara T. A functional polymorphism in fas (CD95/AP0-1) gene promoter associated with systemic lupus erythematosus, J Rheumatol 2002; 29: 1183-1188.
16. Farre L, Bittencourt AL, Silva-Santos G, Almeida A, Silva AC, Decanine D, Soares GM, Alcantara Jr LC, Van Dooren S, Galvão-Castro B, Vandamme AM, Van Weyenbergh J, Fas 670 promoter polymorphism is associated to susceptibility, clinical presentation, and survival in adult T cell leukemia, J Leukoc Biol 2008; 83: 220-222.
17. Sata M, Walsh K, Oxidized LDL activates fas-mediated endothelial cell apoptosis, J Clin Invest 1998; 102: 1682-1689. (Pubitemid 28516253)
18. Sata M, Walsh K, TNFalpha regulation of Fas ligand expression on the vascular endothelium modulates leukocyte extravasation, Nat Med 1998; 4: 415-420 (Pubitemid 28212756)
19. Suhara T, Fukuo K, Sugimoto T, Morimoto S, Nakahashi T, Hata S, Shimizu M, Ogihara T, Hydrogen peroxide induces up-regulation of Fas in human endothelial cells, J Immunol 1998; 160: 4042-4047 (Pubitemid 28176114)
20. Suhara T, Fukuo K, Yasuda O, Tsubakimoto M, Takemura Y, Kawamoto H, Yokoi T, Mogi M, Kaimoto T, Ogihara T, Homocysteine enhances endothelial apoptosis via upregulation of Fas-mediated pathways, Hypertension 2004; 43: 1208-1213 (Pubitemid 38696913)
21. Niinobu T, Fukuo K, Yasuda O, Tsubakimoto M, Mogi M, Nishimaki H, Morimoto S, Ogihara T, Negative feedback regulation of activated macrophages via Fas-mediated apoptosis, Am J Physiol Cell Physiol 2000; 279: C504-C509
22. Shimizu M, Fukuo K, Nagata S, Suhara T, Okuro M, Fujii K, Higashino Y, Mogi M, Hatanaka Y, Ogihara T, Increased plasma levels of the soluble form of Fas ligand in patients with acute myocardial infarction and unstable angina pectoris, J Am Coll Cardiol 2002; 39: 585-590 (Pubitemid 34158152)
23. Kotani N, Fukuo K, Yasuda O, Katuya T, Takemura Y, Kawamoto H, Yokoi T, Suzuki A, Ogihara T, Fas ligand mRNA levels of circulating leukocytes reflect endothelial dysfunction in hyperllpidemlc but not in non-hyperllpidemlc patients, Hypertens Res 2006; 29: 217-225 (Pubitemid 43853267)
24. Fukuo K, Nakahashi T, Nomura S, Hata S, Suhara T, Shimizu M, Tamatani M, Morimoto S, Kitamura Y, Ogihara T, Possible participation of Fas-mediated apoptosis in the mechanism of atherosclerosis, Gerontology 1997; 43(Suppl 1): 35-42. (Pubitemid 27230646)
25. Clarke MC, Figg N, Maguire JJ, Davenport AP, Goddard M, Littlewood TD, Bennett MR, Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis, Nat Med 2006; 12: 1075-1080 (Pubitemid 44353389)
26. Leon ML, Zuckerman SH, Gamma interferon: a central mediator in atherosclerosis, Inflamm Res 2005; 54: 395-411
27. Gupta S, Pablo AM, Jiang X, Wang N, Tall AR, Schindler C, IFN-gamma potentiates atherosclerosis in ApoE knock-out mice, J Clin Invest 1997; 99: 2752-2761 (Pubitemid 27259823)
28. Buono C, Come CE, Stavrakis G, Maguire GF, Connelly PW, Lichtman AH, Influence of interferon-gamma on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse, Arterioscler Thromb Vase Biol 2003; 23: 454-460 (Pubitemid 36337222)
29. Whitman SC, Ravisankar P, Elam H, Daugherty A, Exogenous interferon-gamma enhances atherosclerosis in apollpoprotein E-/- mice, Am J Pathol 2000; 157: 1819-1824
30. Koga M, Kai H, Yasukawa H, Kato S, Yamamoto T, Kawal Y, Kusaba K, Seki Y, Kai M, Egashira K, Kataoka Y, Imaizumi T, Postnatal blocking of interferon-gamma function prevented atherosclerotic plaque formation in apollpoprotein E-knockout mice, Hypertens Res 2007; 30: 259-267 (Pubitemid 46605451)
31. Boehm U, Klamp T, Groot M, Howard JC, Cellular responses to interferon-gamma, Annu Rev Immunol 1997; 15: 749-795
32. Rosner D, Stoneman V, Littlewood T, McCarthy N, Figg N, Wang Y, Tellides G, Bennett M, Interferon-gamma induces Fas trafficking and sensitization to apoptosis in vascular smooth muscle cells via a PI3K- and Akt-dependent mechanism, Am J Pathol 2006; 168: 2054-2063 (Pubitemid 43825323)
33. Kavurma MM, Tan NY, Bennett MR, Death receptors and their ligands in atherosclerosis, Arterioscler Thromb Vase Biol 2008; 28: 1694-1702
34. Takemura Y, Fukuo K, Yasuda O, lnoue T, lnomata N, Yokoi T, Kawamoto H, Suhara T, Ogihara T, Fas signaling induces Akt activation and upregulation of endothelial nitric oxide synthase expression, Hypertension 2004; 43: